The edivoxetine 0.2 mg/kg/day and 0.3 mg/kg/day arms had statistically significantly greater improvement than the placebo arm in mean ADHD-RS total score change at end-point ( placebo -10.35 ; edivoxetine 0.2 mg/kg/day -16.09 , p < 0.010 ; edivoxetine 0.3 mg/kg/day -16.39 , p < 0.010 ) and Clinical Global Impressions-Improvement score ( placebo 3.05 ; edivoxetine 0.1 mg/kg/day 3.01 , p = 0.860 ; edivoxetine 0.2 mg/kg/day 2.54 , p = 0.013 ; edivoxetine 0.3 mg/kg/day 2.53 , p = 0.013 ) .